Beam Therapeutics Inc.BEAMNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank88
3Y CAGR+78.7%
5Y CAGR+76.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+78.7%/yr
vs +64.9%/yr prior
5Y CAGR
+76.1%/yr
Consistent
Acceleration
+13.8pp
Accelerating
Percentile
P88
Within normal range
vs 5Y Ago
16.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $501.14M | +349.4% |
| 2024 | $111.53M | -79.9% |
| 2023 | $554.19M | +531.2% |
| 2022 | $87.81M | -58.6% |
| 2021 | $212.18M | +616.7% |
| 2020 | $29.60M | +44.0% |
| 2019 | $20.55M | +73.2% |
| 2018 | $11.87M | +38.1% |
| 2017 | $8.60M | - |